Trial Profile
A study of Everolimus eluting ABSORB Bioresorbable vascular scaffold (BVS) for treatment of Coronary Bifurcation lesions.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions; Therapeutic Use
- 12 Dec 2015 New trial record